A Comparison of Acute Hemorrhagic Stroke Outcomes in 2 Populations
Author(s) -
Ioannis Zaganas,
Amy P. Halpin,
А. О. Олейник,
Athanasios Alegakis,
Dimitra Kotzamani,
Spiros Zafiris,
Chryssanthi Chlapoutaki,
Dimitris Tsimoulis,
Emmanouil Giannakoudakis,
Nikolaos Chochlidakis,
Aikaterini Ntailiani,
Christina Valatsou,
Efrosini Papadaki,
Antonios Vakis,
Karen L. Furie,
Steven M. Greenberg,
Andreas Plaitakis
Publication year - 2011
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.632174
Subject(s) - medicine , stroke (engine) , acute stroke , intracerebral hemorrhage , emergency medicine , subarachnoid hemorrhage , tissue plasminogen activator , mechanical engineering , engineering
Although corticosteroid use in acute hemorrhagic stroke is not widely adopted, management with intravenous dexamethasone has been standard of care at the University Hospital of Heraklion, Crete with observed outcomes superior to those reported in the literature. To explore this further, we conducted a retrospective, multivariable-adjusted 2-center study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom